
Journal Menu
► ▼ Journal Menu-
- Biomedicines Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
17 December 2024
Article Layout and Template Revised for Future Volumes
We are pleased to announce a series of updates to our template, aimed at improving the readability and overall aesthetics of our publications. These changes have been meticulously designed to enhance the user experience and ensure consistency across all our publications. The updated template will be available for download from the Instructions for Authors page.
The following updates will be applied to articles published in the 2025 volumes, starting on 24 December 2024:
- Main text: The line spacing has been increased to improve the readability of publications;
- Header and footer: The link to the journal website will be removed, as a hyperlink has been integrated into the journal logo. Additionally, the DOI link will be moved from the left-hand side to the right-hand side, and both the header and footer will be slightly raised to achieve a better balance;
- Left information bar: The information provided here has been rearranged for better organization; the CC-BY logo will be removed;
- Font size: The font size used for the abstract, keywords, and first-level headings will be increased.
Furthermore, MDPI journals will continue to use article numbers. This approach enables us to maintain a rapid and efficient production process by being able to define pagination as soon as a paper is accepted.
We hope that the new version of the template will provide users with a better experience and make the process more convenient.
Please contact production@mdpi.com if you have any questions or suggestions.
6 December 2024
Meet Us Online at the 3rd International Electronic Conference on Biomedicines, 12–15 May 2025

Conference: 3rd International Electronic Conference on Biomedicines
Time: 12–15 May 2025, CEST, Online
Website: https://sciforum.net/event/ECB2025
We cordially invite you to attend the above event organized by the MDPI journal Biomedicines (ISSN: 2227-9059; Impact Factor: 3.9). The conference will take place virtually on 12–15 May 2025, CEST.
Conference Chairs:
- Prof. Dr. Felipe Fregni, Harvard Medical School, Boston, MA, USA;
- Prof. Dr. Allan Stensballe, Aalborg University, Aalborg, Denmark;
- Prof. Dr. Georgia Levidou, Paracelsus Medical University, Klinikum Nuremberg, Germany;
- Prof. Dr. Serafino Fazio, Federico II University School of Medicine, Naples, Italy.
The Topics of Interest:
S1. Insulin resistance or hyperinsulinemia;
S2. Immunotherapy and adverse effects;
S3. Tumor microenvironment;
S4. Immune system, tumor immunology, and autoimmune disease;
S5. Biomedicine in cardiovascular diseases;
S6. Diabetes, obesity and metabolic diseases;
S7. Gene therapy and gene editing;
S8. Rare diseases;
S9. Molecular mechanisms of neurodegeneration.
Important Dates:
Deadline for abstract submission: 19 January 2025;
Notification of acceptance: 19 February 2025;
Deadline for free registration: 8 May 2025.
Submit your abstract here.
Register for the conference here.
For any inquiries regarding the event, please contact ecb@mdpi.com. We look forward to seeing you at ECB2025.
6 December 2024
MDPI INSIGHTS: The CEO's Letter #18 - MDPI UK, Basel Job Fair, CETEF'24

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI’s First UK Summit Held in Manchester
On 29 November, we hosted our first annual MDPI UK Summit, bringing together over 30 Chief Editors and Editorial Board Members (EBMs) to discuss MDPI’s mission, achievements, and collaborations in the UK.
Throughout the day we had talks from several members of MDPI, roundtable discussions on the peer-review process and upholding research integrity, and an engaging presentation from the Editor-in-Chief (EiC) of MDPI journal Mathematics, Francisco Chiclana, about his involvement with the Research Excellence Framework.
“This was a great first summit for MDPI UK and received excellent feedback”
In the following I highlight some of the sessions and the discussion topics covered in each session.
Session 1: Opening Speech and Introduction to MDPI
I shared an overview of MDPI’s mission, achievements, and commitment to quality. The Q&A touched on key topics such as perception and reputation management, expanding our arts and humanities portfolio, and funding challenges for open access (OA) in the UK.
A takeaway from this session was that in 2025, we will circulate a mini annual report to all editors, helping them understand MDPI’s mission and achievements beyond the context of their specific journals.
Session 2: MDPI and the Research Excellence Framework (REF)
Prof. Francisco Chiclana (EiC of Mathematics) highlighted MDPI’s role in REF, its purpose, and future directions.
Session 3: Editorial Process, Ethics, and Research Integrity
Dr. Giulia Stefenelli presented on the various editorial roles and responsibilities, quality metrics, and procedures for dealing with misconduct. The Q&A centred on AI in publishing, institutional roles in research integrity, and better data management practices.
Session 4: Institutional Open Access Program (IOAP)
Becky Castellon presented on IOAP benefits, including MDPI’s partnership with JISC, which includes more than 60 UK institutions, and highlighted the advantages of pure OA over transformative agreements.
Session 5: Round Table Discussion
Colleagues from our MDPI Manchester office Jaime Anderson and Dr. Michael O’Sullivan, along with colleagues from our Basel office Damaris Critchlow and Giulia Stefenelli, discussed innovations in peer review, challenges in maintaining scientific integrity, and future solutions.
Session 6: MDPI PR and the Voice of the Customer
I recapped our customer satisfaction drivers, including speed and editorial support. I also spoke about tackling misinformation about OA and MDPI in general, and outlined a way forward for us all to participate in advocating for open science.
This was a great first summit for MDPI UK and received excellent feedback from our EiCs, SEiCs, and EBMs. A BIG thank-you to our Manchester team (pictured below) and everyone else involved in organizing this event. Their hard work and dedication are much appreciated!
Impactful Research
MDPI and UK Publications
The UK is an important market for MDPI, ranking ninth in total submissions to MDPI and eighth in total MDPI publications, with over 72,200 publications to date. As at October 2024, there were more than 3,600 EBMs from the UK, 48% of whom have an H-index above 26. We also have 46 EiCs, and 63 SEiCs in the UK, some of whom joined us in Manchester for the UK Summit.
The UK is a strong advocate of OA publishing, with nearly three quarters of all articles in 2023 published on open access platforms. The country enjoys a large academic market, producing high-quality papers, and is home to some of the world’s top universities. Among MDPI’s 825 IOAP agreements, over 60 of these are in the UK, facilitated through our partnership with JISC.
“The UK is a strong advocate of OA publishing”
Visit to MDPI’s Manchester Office
Last week, I visited our Manchester office to see the expanding office space, connect with our staff, and present at the MDPI UK Summit held in Manchester.
Throughout the day, I met with various teams to better understand their work and discuss their future development plans in greater depth. Hearing from group leads about the progress we have made and the challenges we face offered many valuable insights. I also had the chance to connect personally with members of the content team. It’s great to see how this young and ambitious team is coming together.
I also took the opportunity to address the entire office about the role of MDPI UK within the wider company. During this session, I answered questions about growth and public relations initiatives. Giulia Stefenelli joined us to address questions about the role of AI in MDPI’s future.
Jaime Anderson (Office Manager) and the Manchester team have done a great job of growing the office since its establishment in 2019. Today, it has around 150 staff members across various departments, including English editing, editorial services, marketing and communications, and IOAP. The team is highly active in local marketing initiatives, such as author training sessions, scholar visits, and conferences.
For more information and updates on our Manchester office, follow MDPI UK on LinkedIn.
Inside MDPI
Basel Job Fair
In November, the HR team from our Basel office connected with over 300 young professionals at the Basel Job Fair 2024. This is my biased opinion, of course, but we had the best branded booth and merchandise, which drew a lot of attention from young talent wanting to learn about current and future job opportunities at MDPI.
Our HR team also helped review CVs on the spot, providing advice on how to improve them and making a positive impression on the future workforce in Basel.
This is a reminder that MDPI is not only focused on supporting young researchers but that we also recruit and develop young talent. We have seen MDPI HR do this really well throughout all of our offices, from Asia Pacific to Europe and North America.
HR plays an important role in our growing company, helping us meet our recruitment targets as well as providing support for local teams, guidance on management and best practices, a safe space for employees, and brand recognition for MDPI, among many other things.
“MDPI is not only focused on supporting young researchers: we also recruit and develop young talent”
This is a quick appreciation post to all HR staff working to support MDPI and our colleagues, cultivating talent and supporting careers at every stage. Thanks HR staff, keep up the great work!
Coming Together for Science
Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life (The 20th Anniversary)
I am pleased to share that the Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life took place from 27 to 29 November 2024 in Barcelona, Spain. It was chaired by Prof. Dr. Amelia Pilar Rauter from the Universidade de Lisboa, Portugal; Dr. Alfredo Berzal Herranz from Instituto de Parasitología y Biomedicina López-Neyra (IPBLN) CSIC, Spain; and Prof. Dr. Mary Jane Meegan from Trinity College Dublin, Ireland.
The conference took place in Casa Convalescència, a part of the Sant Pau Art Nouveau Site. The three-day event included three plenary sessions and eight invited speakers, from eight countries, and 29 selected talks. Of the presentations on site, there were 32 posters and 29 oral presentations.
The main goal of the ‘Pharmaceuticals 2024’ international conference was to cover the newest technologies and research areas including medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, in a meeting that brought together experts to present their latest findings on combatting infection, inflammation, pain, and neurodegeneration, to mention just a few of the topics that were discussed.
“The main goal of ‘Pharmaceuticals 2024’ was to cover the newest technologies and research areas”
20th Anniversary of Pharmaceuticals
The year 2024 marks the 20th anniversary of Pharmaceuticals – a journal dedicated to medicinal chemistry and related drug sciences, which is published monthly online by MDPI. To honour this milestone, we are reflecting on our past accomplishments and embarking on an exciting new chapter. This celebration is also one of the reasons why we organized the conference Pharmaceuticals 2024. With an Impact Factor of 4.3 and a CiteScore of 6.1, the journal is covered in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus/SciFinder, and other databases. Pharmaceuticals has published over 6,000 papers from more than 37,000 authors. More than 10,000 reviewers have reviewed for it at least once.
20th Anniversary of Pharmaceuticals: The Video
This video captures the experiences of the conference chairs, honorary guests and committee members of the conference.
Thank you to our partnering societies
A special thank-you is due to our partnering societies the Spanish Society Of Medicinal Chemistry (SEQT) and the Spanish Society For Biochemistry And Molecular Biology (SEBBM) for their support of the Pharmaceuticals 2024 conference. I am also pleased to report that we presented two awards, sponsored by the journal Pharmaceuticals, including the Best Presentation Award and the Best Oral Presentation Award, recognizing the contributions of our participants.
Closing Thoughts
Presenting at the 4th Central European Technology Forum
I visited Krakow, Poland in November to participate in the 4th Central European Technology Forum (CETEF’24), which took place on 18 and 19 November.
CETEF is an international conference that has been jointly organized since 2014 by the Polish Chamber of Commerce for Advanced Technologies (IZTECH) and the Polish Federation of Engineering Associations, with the support of the European Parliament and the European Commission, in cooperation with universities, research institutes and the high-tech industry. The 2024 event focused on presentation to advance the European science and technology agenda for 2025–2030.
MDPI participated as a key publishing sponsor. We had an exhibition booth and held two key presentations during the conference. On Monday, I presented MDPI’s vision, purpose, and achievements.
On Tuesday, Dr. Giulia Stefenelli shared how MDPI supports advancements in high technology and energy transition, highlighting our portfolio, services, tools and initiatives for promoting progress and interdisciplinary collaboration.
We received positive feedback from scientists and government representatives in attendance.
A big thank-you goes to our colleagues from the Krakow office for their support in organizing our participation and managing the MDPI booth.
Special thanks are owing to Weronika Gorka-Kumik, Igor Matic, Vincent Di, Agnieszka Rydz, Ksenia Shubenkova, Anna Krakowka and Klaudia Kasprowicz.
Below is a photo with the President of the Polish Chamber of Commerce conference (centre), along with MDPI colleagues Giulia Stefenelli, Weronika Gorka-Kumik, and Igor Matic (left to right).
“This year’s event focused on ideas and proposals to advance the European science and technology agenda for 2025–2030”
Chief Executive Officer
MDPI AG
4 December 2024
685 MDPI Editors Named Highly Cited Researchers in 2024

We extend our heartfelt congratulations to the 685 Editorial Board Members of our journals – from 39 different countries and territories – who have been recognized as Highly Cited Researchers for 2024 by Clarivate. This distinction highlights their exceptional scientific achievements and significant contributions, which transcend academic boundaries to advance global knowledge, sustainability, security, and well-being.
Clarivate's annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade, whose work has had a profound and widespread impact across various scientific and social science disciplines. Their impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the "Essential Science Indicators," marking them as leaders in their respective domains.
"Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research," according to Clarivate. In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals.
The following is a list of MDPI's Editorial Board Members named Highly Cited Researchers in 2024. We congratulate them for their achievement and their contributions to advancing knowledge in their respective fields.
Abate, Antonio |
Jiang, Lianzhou |
Song, Jibin |
25 November 2024
Biomedicines | Hot Papers in the “Molecular Genetics and Genetic Diseases” Section
The “Molecular Genetics and Genetic Diseases” Section covers the basic and translational aspects of human genetic disease and genomic research, from fundamental molecular investigations to preclinical animal models. In particular, this Section aims to facilitate the rapid publication of innovative research encompassing the genetic basis of human health and disease, as well as the treatment of genetic disorders and heritable or acquired cancers. We welcome submissions that apply new and emerging technologies in the fields of genomics, transcriptomics, and bioinformatic tools to advance knowledge in human genetic diseases.
1. “Sensitivity Analysis for Survival Prognostic Prediction with Gene Selection: A Copula Method for Dependent Censoring”
by Chih-Tung Yeh, Gen-Yih Liao and Takeshi Emura
Biomedicines 2023, 11(3), 797; https://doi.org/10.3390/biomedicines11030797
Available online: https://www.mdpi.com/2227-9059/11/3/797
2. “Targeted DNA Demethylation: Vectors, Effectors and Perspectives”
by Naohiro Yano and Alexey V. Fedulov
Biomedicines 2023, 11(5), 1334; https://doi.org/10.3390/biomedicines11051334
Available online: https://www.mdpi.com/2227-9059/11/5/1334
3. “Increasing Specificity of Targeted DNA Methylation Editing by Non-Enzymatic CRISPR/dCas9-Based Steric Hindrance”
by Daniel M. Sapozhnikov and Moshe Szyf
Biomedicines 2023, 11(5), 1238; https://doi.org/10.3390/biomedicines11051238
Available online: https://www.mdpi.com/2227-9059/11/5/1238
4. “The Enigmatic Genetic Landscape of Hereditary Hearing Loss: A Multistep Diagnostic Strategy in the Italian Population”
by Beatrice Spedicati, Aurora Santin, Giuseppe Giovanni Nardone, Elisa Rubinato, Stefania Lenarduzzi, Claudio Graziano, Livia Garavelli, Sara Miccoli, Stefania Bigoni, Anna Morgan et al.
Biomedicines 2023, 11(3), 703; https://doi.org/10.3390/biomedicines11030703
Available online: https://www.mdpi.com/2227-9059/11/3/703
5. “Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss”
by Joey Lye, Derek S. Delaney, Fiona K. Leith, Varda S. Sardesai, Samuel McLenachan, Fred K. Chen, Marcus D. Atlas and Elaine Y. M. Wong
Biomedicines 2023, 11(12), 3347; https://doi.org/10.3390/biomedicines11123347
Available online: https://www.mdpi.com/2227-9059/11/12/3347
6. “Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review”
by Emanuele Bernardinelli, Florian Huber, Sebastian Roesch and Silvia Dossena
Biomedicines 2023, 11(6), 1695; https://doi.org/10.3390/biomedicines11061695
Available online: https://www.mdpi.com/2227-9059/11/6/1695
7. “CT-Based Radiomics to Predict KRAS Mutation in CRC Patients Using a Machine Learning Algorithm: A Retrospective Study”
by Jacobo Porto-Álvarez, Eva Cernadas, Rebeca Aldaz Martínez, Manuel Fernández-Delgado, Emilio Huelga Zapico, Víctor González-Castro, Sandra Baleato-González, Roberto García-Figueiras, J Ramon Antúnez-López and Miguel Souto-Bayarri
Biomedicines 2023, 11(8), 2144; https://doi.org/10.3390/biomedicines11082144
Available online: https://www.mdpi.com/2227-9059/11/8/2144
8. “Panoramic on Epigenetics in Coronary Artery Disease and the Approach of Personalized Medicine”
by Marcello Bergonzini, Francesco Loreni, Antonio Lio, Marco Russo, Guglielmo Saitto, Antonio Cammardella, Francesco Irace, Corrado Tramontin, Massimo Chello, Mario Lusini et al.
Biomedicines 2023, 11(10), 2864; https://doi.org/10.3390/biomedicines11102864
Available online: https://www.mdpi.com/2227-9059/11/10/2864
9. “Systemic and Airway Epigenetic Disruptions Are Associated with Health Status in COPD”
by Ana I. Hernandez Cordero, Xuan Li, Chen Xi Yang, Julia Yang, Julia L. MacIsaac, Kristy Dever, Michael S. Kobor, Stephen Milne, Stephan F. van Eeden, Tawimas Shaipanich et al.
Biomedicines 2023, 11(1), 134; https://doi.org/10.3390/biomedicines11010134
Available online: https://www.mdpi.com/2227-9059/11/1/134
10. “Chronic Pelvic Pain, Vulvar Pain Disorders, and Proteomics Profiles: New Discoveries, New Hopes”
by Chiara Di Tucci and Ludovico Muzii
Biomedicines 2024, 12(1), 1; https://doi.org/10.3390/biomedicines12010001
Available online: https://www.mdpi.com/2227-9059/12/1/1
We would like to take this opportunity to thank all the research groups that have submitted their research to Biomedicines (ISSN: 2227-9059). We would appreciate it if you could circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:
Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.
Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.
Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).
Biomedicines Editorial Office
25 November 2024
Biomedicines | Hot Papers in the “Molecular and Translational Medicine” Section
The “Molecular and Translational Medicine” Section publishes reviews and original peer-reviewed papers which aim to cover studies concerning disease pathogenesis at the molecular or physiological level, as well as the basic preclinical, clinical, and translational aspects. We encourage scientists to submit their results that have the potential for application in human disease, as well as research obtained from clinical trials or animal models of human diseases, with the potential to shed light on the underlying causes of various human diseases and cancer, to develop future human medicines, medical devices, and diagnostics. In this context, we are pleased to feature some recently published papers on molecular and translational medicine in Biomedicines (ISSN: 2227-9059), which will provide valuable insights into this exciting field.
1. “The Role of Glutamate Receptors in Epilepsy”
by Tsang-Shan Chen, Tzu-Hsin Huang, Ming-Chi Lai and Chin-Wei Huang
Biomedicines 2023, 11(3), 783; https://doi.org/10.3390/biomedicines11030783
Available online: https://www.mdpi.com/2227-9059/11/3/783
2. “From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications”
by Andrea Boccatonda, Lorenzo Andreetto, Damiano D’Ardes, Giulio Cocco, Ilaria Rossi, Susanna Vicari, Cosima Schiavone, Francesco Cipollone and Maria Teresa Guagnano
Biomedicines 2023, 11(3), 883; https://doi.org/10.3390/biomedicines11030883
Available online: https://www.mdpi.com/2227-9059/11/3/883
3. “Efficacy of Pulmonary Rehabilitation in Post-COVID-19: A Systematic Review and Meta-Analysis”
by Erika Meléndez-Oliva, Oliver Martínez-Pozas, Juan Nicolás Cuenca-Zaldívar, Jorge Hugo Villafañe, Laura Jiménez-Ortega and Eleuterio A. Sánchez-Romero
Biomedicines 2023, 11(8), 2213; https://doi.org/10.3390/biomedicines11082213
Available online: https://www.mdpi.com/2227-9059/11/8/2213
4. “Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?”
by Katharina Staufer and Rudolf E. Stauber
Biomedicines 2023, 11(8), 2108; https://doi.org/10.3390/biomedicines11082108
Available online: https://www.mdpi.com/2227-9059/11/8/2108
5. “Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study”
by Alfredo Caturano, Raffaele Galiero, Giuseppe Loffredo, Erica Vetrano, Giulia Medicamento, Carlo Acierno, Luca Rinaldi, Aldo Marrone, Teresa Salvatore, Marcellino Monda et al.
Biomedicines 2023, 11(2), 322; https://doi.org/10.3390/biomedicines11020322
Available online: https://www.mdpi.com/2227-9059/11/2/322
6. “Impact of Hyper- and Hypo-Uricemia on Kidney Function”
by Junichiro Miake, Ichiro Hisatome, Katsuyuki Tomita, Tadahiro Isoyama, Shinobu Sugihara, Masanari Kuwabara, Kazuhide Ogino and Haruaki Ninomiya
Biomedicines 2023, 11(5), 1258; https://doi.org/10.3390/biomedicines11051258
Available online: https://www.mdpi.com/2227-9059/11/5/1258
7. “Air Pollution as a Risk Indicator for Periodontitis”
by Crystal Marruganti, Hye-Sun Shin, Seon-Ju Sim, Simone Grandini, Andreina Laforí and Mario Romandini
Biomedicines 2023, 11(2), 443; https://doi.org/10.3390/biomedicines11020443
Available online: https://www.mdpi.com/2227-9059/11/2/443
8. “Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications”
by Zach J. Leinen, Rahul Mohan, Lakmini S. Premadasa, Arpan Acharya, Mahesh Mohan and Siddappa N. Byrareddy
Biomedicines 2023, 11(10), 2630; https://doi.org/10.3390/biomedicines11102630
Available online: https://www.mdpi.com/2227-9059/11/10/2630
9. “Novel Therapies for the Prevention of Fibrosis in Glaucoma Filtration Surgery”
by Christine G. Shao, Nishant R. Sinha, Rajiv R. Mohan and Aaron D. Webel
Biomedicines 2023, 11(3), 657; https://doi.org/10.3390/biomedicines11030657
Available online: https://www.mdpi.com/2227-9059/11/3/657
10. “Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies”
by Elisabetta Bretto, Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Giorgio Maria Saracco, Elisabetta Bugianesi and Simone Frara
Biomedicines 2023, 11(8), 2249; https://doi.org/10.3390/biomedicines11082249
Available online: https://www.mdpi.com/2227-9059/11/8/2249
We would like to take this opportunity to thank all the research groups that have submitted their research to Biomedicines. We would appreciate it if you could circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:
Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.
Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.
Joining the Editorial Board:
If you are an active researcher in the fields of biomedical research and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).
Biomedicines Editorial Office
25 November 2024
Biomedicines | Hot Papers in the “Neurobiology and Clinical Neuroscience” Section
The “Neurobiology and Clinical Neuroscience” Section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the treatment of neurobiology and neurologic diseases. Topics include, but are not limited to, neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics; in vitro and in vivo responses to neurological diseases; the identification of therapeutic targets; the evaluation of diagnostic markers; and the assessment of therapies for neurological disorders.
1. “Metals in Alzheimer’s Disease”
by Mirjana Babić Leko, Lea Langer Horvat, Ena Španić Popovački, Klara Zubčić, Patrick R. Hof and Goran Šimić
Biomedicines 2023, 11(4), 1161; https://doi.org/10.3390/biomedicines11041161
Available online: https://www.mdpi.com/2227-9059/11/4/1161
2. “Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment”
by Luca Marsili, Samuel Marcucci, Joseph LaPorta, Martina Chirra, Alberto J. Espay and Carlo Colosimo
Biomedicines 2023, 11(5), 1406; https://doi.org/10.3390/biomedicines11051406
Available online: https://www.mdpi.com/2227-9059/11/5/1406
3. “Screening for Neuroprotective and Rapid Antidepressant-like Effects of 20 Essential Oils”
by Khoa Nguyen Tran, Nhi Phuc Khanh Nguyen, Ly Thi Huong Nguyen, Heung-Mook Shin and In-Jun Yang
Biomedicines 2023, 11(5), 1248; https://doi.org/10.3390/biomedicines11051248
Available online: https://www.mdpi.com/2227-9059/11/5/1248
4. “Cerebrospinal Fluid–Basic Concepts Review”
by Natalia Czarniak, Joanna Kamińska, Joanna Matowicka-Karna and Olga Martyna Koper-Lenkiewicz
Biomedicines 2023, 11(5), 1461; https://doi.org/10.3390/biomedicines11051461
Available online: https://www.mdpi.com/2227-9059/11/5/1461
5. “Neurophysiological Markers of Premotor–Motor Network Plasticity Predict Motor Performance in Young and Older Adults”
by Sonia Turrini, Naomi Bevacqua, Antonio Cataneo, Emilio Chiappini, Francesca Fiori, Simone Battaglia, Vincenzo Romei and Alessio Avenanti
Biomedicines 2023, 11(5), 1464; https://doi.org/10.3390/biomedicines11051464
Available online: https://www.mdpi.com/2227-9059/11/5/1464
6. “Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human”
by Martina Montanari, Paola Imbriani, Paola Bonsi, Giuseppina Martella and Antonella Peppe
Biomedicines 2023, 11(6), 1560; https://doi.org/10.3390/biomedicines11061560
Available online: https://www.mdpi.com/2227-9059/11/6/1560
7. “Increased Risk of Aging-Related Neurodegenerative Disease after Traumatic Brain Injury”
by Sarah Barker, Bindu D. Paul and Andrew A. Pieper
Biomedicines 2023, 11(4), 1154; https://doi.org/10.3390/biomedicines11041154
Available online: https://www.mdpi.com/2227-9059/11/4/1154
8. “Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era”
by Andrei Surguchov, Fatemeh N. Emamzadeh, Mariya Titova and Alexei A. Surguchev
Biomedicines 2023, 11(4), 1215; https://doi.org/10.3390/biomedicines11041215
Available online: https://www.mdpi.com/2227-9059/11/4/1215
9. “Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder”
by Fabiola De Marchi, Toni Franjkic, Paride Schito, Tommaso Russo, Jerneja Nimac, Anna A. Chami, Angelica Mele, Lea Vidatic, Jasna Kriz, Jean-Pierre Julien et al.
Biomedicines 2023, 11(6), 1599; https://doi.org/10.3390/biomedicines11061599
Available online: https://www.mdpi.com/2227-9059/11/6/1599
10. “The Vascular-Immune Hypothesis of Alzheimer’s Disease”
by Rashi I. Mehta and Rupal I. Mehta
Biomedicines 2023, 11(2), 408; https://doi.org/10.3390/biomedicines11020408
Available online: https://www.mdpi.com/2227-9059/11/2/408
We would like to take this opportunity to thank all the research groups that have submitted their research to Biomedicines (ISSN: 2227-9059). We would appreciate it if you could circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:
Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.
Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.
Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).
25 November 2024
Biomedicines | Hot Papers in the “Nanomedicine and Nanobiology” Section
The “Nanomedicine and Nanobiology” Section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of nanomedicine. The papers are aimed at providing insights into the synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; and interactions of nanomaterials with cells, tissues, and living organisms. In this context, we are pleased to feature some recently published papers on nanomedicine and nanobiology in Biomedicines (ISSN: 2227-9059), which provide valuable insights into this exciting field.
1. “Urinary Biomarkers and Point-of-Care Urinalysis Devices for Early Diagnosis and Management of Disease: A Review”
by Beatriz Sequeira-Antunes and Hugo Alexandre Ferreira
Biomedicines 2023, 11(4), 1051; https://doi.org/10.3390/biomedicines11041051
Available online: https://www.mdpi.com/2227-9059/11/4/1051
2. “Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety”
by Md Sazzad Hassan, Niranjan Awasthi, Saisantosh Ponna and Urs von Holzen
Biomedicines 2023, 11(7), 2000; https://doi.org/10.3390/biomedicines11072000
Available online: https://www.mdpi.com/2227-9059/11/7/2000
3. “Nucleic Acid Aptamer-Based Biosensors: A Review”
by Beatriz Sequeira-Antunes and Hugo Alexandre Ferreira
Biomedicines 2023, 11(12), 3201; https://doi.org/10.3390/biomedicines11123201
Available online: https://www.mdpi.com/2227-9059/11/12/3201
4. “Identification of Geometrical Features of Cell Surface Responsible for Cancer Aggressiveness: Machine Learning Analysis of Atomic Force Microscopy Images of Human Colorectal Epithelial Cells”
by Mikhail Petrov and Igor Sokolov
Biomedicines 2023, 11(1), 191; https://doi.org/10.3390/biomedicines11010191
Available online: https://www.mdpi.com/2227-9059/11/1/191
5. “Detection of Biological Molecules Using Nanopore Sensing Techniques”
by Iuliana Șoldănescu, Andrei Lobiuc, Mihai Covașă and Mihai Dimian
Biomedicines 2023, 11(6), 1625; https://doi.org/10.3390/biomedicines11061625
Available online: https://www.mdpi.com/2227-9059/11/6/1625
6. “Inhaled Exosomes Genetically Manipulated to Overexpress CD24 (EXO-CD24) as a Compassionate Use in Severe ARDS Patients”
by Orr Green, Gil Shenberg, Roni Baruch, Lihi Argaman, Talya Levin, Ian Michelson, Ruthy Hadary, Boris Isakovich, Miri Golos, Reut Schwartz et al.
Biomedicines 2023, 11(9), 2523; https://doi.org/10.3390/biomedicines11092523
Available online: https://www.mdpi.com/2227-9059/11/9/2523
7. “Optimizing Dental Bond Strength: Insights from Comprehensive Literature Review and Future Implications for Clinical Practice”
by Yung-Shin Fan-Chiang, Peng-Chen Chou, Yu-Wen Hsiao, Yu-Hsuan Cheng, Yi Huang, Yu-Chieh Chiu, Yu-Ju Lin, Yuichi Mine, Sheng-Wei Feng, I-Ta Lee et al.
Biomedicines 2023, 11(11), 2995; https://doi.org/10.3390/biomedicines11112995
Available online: https://www.mdpi.com/2227-9059/11/11/2995
8. “Fabrication of a Smart Fibrous Biomaterial That Harbors an Active TGF-β1 Peptide: A Promising Approach for Cartilage Regeneration”
by Aglaia Mantsou, Eleni Papachristou, Panagiotis Keramidas, Paraskevas Lamprou, Maria Pitou, Rigini M. Papi, Katerina Dimitriou, Amalia Aggeli and Theodora Choli-Papadopoulou
Biomedicines 2023, 11(7), 1890; https://doi.org/10.3390/biomedicines11071890
Available online: https://www.mdpi.com/2227-9059/11/7/1890
9. “Advancing Cancer Treatment: Enhanced Combination Therapy through Functionalized Porous Nanoparticles”
by Kibeom Kim and Myoung-Hwan Park
Biomedicines 2024, 12(2), 326; https://doi.org/10.3390/biomedicines12020326
Available online: https://www.mdpi.com/2227-9059/12/2/326
10. “Nanotechnology Innovations in Pediatric Cardiology and Cardiovascular Medicine: A Comprehensive Review”
by Stefana Maria Moisa, Alexandru Burlacu, Lacramioara Ionela Butnariu, Corina Maria Vasile, Crischentian Brinza, Elena Lia Spoiala, Alexandra Maștaleru, Maria Magdalena Leon, Solange Tamara Rosu, Radu Vatasescu et al.
Biomedicines 2024, 12(1), 185; https://doi.org/10.3390/biomedicines12010185
Available online: https://www.mdpi.com/2227-9059/12/1/185
We would like to take this opportunity to thank all the research groups that have submitted their papers to Biomedicines. We would appreciate it if you could circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:
Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.
Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.
Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).
Biomedicines Editorial Office
25 November 2024
Biomedicines | Hot Papers in the “Microbiology in Human Health and Disease” Section
Microorganisms are an essential part of life on Earth and play an important role in almost every natural cycle. The “Microbiology in Human Health and Disease” Section focuses on microbiology in the contexts of human health and diseases, including infectious diseases, the interactions between pathogenic microorganisms and hosts, bacteriology, mycology, virology, and parasitology. The perspective of the Section is that microorganisms and public health are closely intertwined and that advances in one area will have positive consequences in another.
1. “Antifungal Drug Resistance: An Emergent Health Threat”
by Antonio Vitiello, Francesco Ferrara Emilio Comberiati, Andrea Zovi, Mariarosaria Boccellino, Annarita Ponzo, Carla Cimmino, , Salvatore Clemente and Michela Sabbatucci
Biomedicines 2023, 11(4), 1063; https://doi.org/10.3390/biomedicines11041063
Available online: https://www.mdpi.com/2227-9059/11/4/1063
2. “Fecal Microbiota Transplantation in Liver Cirrhosis”
by Adrian Boicean, Victoria Birlutiu, Cristian Ichim, Olga Brusnic and Danusia Maria Onisor
Biomedicines 2023, 11(11), 2930; https://doi.org/10.3390/biomedicines11112930
Available online: https://www.mdpi.com/2227-9059/11/11/2930
3. “The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature”
by Georgios Vakadaris, Christos Stefanis, Elpida Giorgi Chrysoula (Chrysa) Voidarou, Yiannis Kourkoutas, Merkourios Brouvalis, Christina Tsigalou and Eugenia Bezirtzoglou
Biomedicines 2023, 11(2), 494; https://doi.org/10.3390/biomedicines11020494
Available online: https://www.mdpi.com/2227-9059/11/2/494
4. “HERVs and Cancer—A Comprehensive Review of the Relationship of Human Endogenous Retroviruses and Human Cancers”
by Erik Stricker, Erin C. Peckham-Gregory and Michael E. Scheurer
Biomedicines 2023, 11(3), 936; https://doi.org/10.3390/biomedicines11030936
Available online: https://www.mdpi.com/2227-9059/11/3/936
5. “Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC)”
by Ian Z. Ong, Dennis L. Kolson and Matthew K. Schindler
Biomedicines 2023, 11(2), 377; https://doi.org/10.3390/biomedicines11020377
Available online: https://www.mdpi.com/2227-9059/11/2/377
6. “COVID-19, Blood Lipid Changes, and Thrombosis”
by Akhlaq A. Farooqui, Tahira Farooqui, Grace Y. Sun, Teng-Nan Lin, Daniel B. L. Teh and Wei-Yi Ong
Biomedicines 2023, 11(4), 1181; https://doi.org/10.3390/biomedicines11041181
Available online: https://www.mdpi.com/2227-9059/11/4/1181
7. “Inhibition of Multidrug Efflux Pumps Belonging to the Major Facilitator Superfamily in Bacterial Pathogens”
by Manuel F. Varela, Jerusha Stephen, Deeksha Bharti, Manjusha Lekshmi and Sanath Kumar
Biomedicines. 2023, 11(5), 1448; https://doi.org/10.3390/biomedicines11051448
Available online: https://www.mdpi.com/2227-9059/11/5/1448
8. “Suppressive Effects of Lactobacillus on Depression through Regulating the Gut Microbiota and Metabolites in C57BL/6J Mice Induced by Ampicillin”
by Wan-Hua Tsai, Wen-Ling Yeh, Chia-Hsuan Chou, Chia-Lin Wu, Chih-Ho Lai, Yao-Tsung Yeh, Chorng-An Liao and Chih-Chung Wu
Biomedicines. 2023, 11(4), 1068; https://doi.org/10.3390/biomedicines11041068
Available online: https://www.mdpi.com/2227-9059/11/4/1068
9. “In Vitro Activity of Eravacycline against Carbapenemase-Producing Gram-Negative Bacilli Clinical Isolates in Central Poland”
by Małgorzata Brauncajs, Filip Bielec, Anna Macieja and Dorota Pastuszak-Lewandoska
Biomedicines. 2023, 11(7), 1784; https://doi.org/10.3390/biomedicines11071784
Available online: https://www.mdpi.com/2227-9059/11/7/1784
10. “Chronic Endometritis and Uterine Endometrium Microbiota in Recurrent Implantation Failure and Recurrent Pregnancy Loss”
by Kanako Takimoto, Hideto Yamada, Shigeki Shimada, Yoshiyuki Fukushi and Shinichiro Wada
Biomedicines. 2023, 11(9), 2391; https://doi.org/10.3390/biomedicines11092391
Available online: https://www.mdpi.com/2227-9059/11/9/2391
We would like to take this opportunity to thank all the research groups that have submitted their papers to Biomedicines (ISSN: 2227-9059). We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:
Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.
Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.
Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).
Biomedicines Editorial Office
25 November 2024
Biomedicines | Hot Papers in the “Cell Biology and Pathology” Section
The “Cell Biology and Pathology” Section covers all aspects of this general field, from molecular machines that enable or adversely modify cell function to the pathology of complete organisms. Both review articles and original research contributions are welcome, as long as they conform to the highest scientific standards. Contributions that explore the origin of diseases at the molecular level, such as structural, biochemical, and genetic studies of receptors, oncogenes, tumor suppressor and regulatory proteins, signal pathways, RNA/DNA, as well as articles that propose new routes for the cure and prevention of diseases, are of particular interest. Cutting-edge diagnostic tools ranging from PCR to magnetic resonance, as applied to the detection of cellular or organismic pathological dysfunctions on all levels, will be accepted. In this context, we are pleased to feature some recently published papers on cell biology and pathology in Biomedicines (ISSN: 2227-9059), which provide valuable insights into this exciting field.
1. “Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment”
by Ferenc Sipos and Györgyi Műzes
Biomedicines 2023, 11(1), 189; https://doi.org/10.3390/biomedicines11010189
Available online: https://www.mdpi.com/2227-9059/11/1/189
2. “IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?”
by Antonino Belfiore, Rosaria Valentina Rapicavoli, Rosario Le Moli, Rosamaria Lappano, Andrea Morrione, Ernestina Marianna De Francesco and Veronica Vella
Biomedicines 2023, 11(1), 229; https://doi.org/10.3390/biomedicines11010229
Available online: https://www.mdpi.com/2227-9059/11/1/229
3. “SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease”
by Manuel Alfredo Podestà, Gianmarco Sabiu, Andrea Galassi, Paola Ciceri and Mario Cozzolino
Biomedicines 2023, 11(2), 279; https://doi.org/10.3390/biomedicines11020279
Available online: https://www.mdpi.com/2227-9059/11/2/279
4. “The Imbalance of Astrocytic Mitochondrial Dynamics Following Blast-Induced Traumatic Brain Injury”
by Fernanda Guilhaume-Correa, Alicia M. Pickrell and Pamela J. VandeVord
Biomedicines 2023, 11(2), 329; https://doi.org/10.3390/biomedicines11020329
Available online: https://www.mdpi.com/2227-9059/11/2/329
5. “Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia”
by Mateusz Górecki, Ilona Kozioł, Agnieszka Kopystecka, Julia Budzyńska, Joanna Zawitkowska and Monika Lejman
Biomedicines 2023, 11(3), 821; https://doi.org/10.3390/biomedicines11030821
Available online: https://www.mdpi.com/2227-9059/11/3/821
6. “Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart Failure”
by Mei Li Ng, Xu Ang, Kwan Yi Yap, Jun Jie Ng, Eugene Chen Howe Goh, Benjamin Bing Jie Khoo, Arthur Mark Richards and Chester Lee Drum
Biomedicines 2023, 11(3), 917; https://doi.org/10.3390/biomedicines11030917
Available online: https://www.mdpi.com/2227-9059/11/3/917
7. “RAGE Inhibitors in Neurodegenerative Diseases”
by V. Prakash Reddy, Puspa Aryal and Pallavi Soni
Biomedicines 2023, 11(4), 1131; https://doi.org/10.3390/biomedicines11041131
Available online: https://www.mdpi.com/2227-9059/11/4/1131
8. “Collagens Regulating Adipose Tissue Formation and Functions”
by Iida Jääskeläinen, Tiina Petäistö, Elahe Mirzarazi Dahagi, Mahdokht Mahmoodi, Taina Pihlajaniemi, Mari T. Kaartinen and Ritva Heljasvaara
Biomedicines 2023, 11(5), 1412; https://doi.org/10.3390/biomedicines11051412
Available online: https://www.mdpi.com/2227-9059/11/5/1412
9. “Biomechanics of Chondrocytes and Chondrons in Healthy Conditions and Osteoarthritis: A Review of the Mechanical Characterisations at the Microscale”
by Sofia Pettenuzzo, Alessandro Arduino, Elisa Belluzzi, Assunta Pozzuoli, Chiara Giulia Fontanella, Pietro Ruggieri, Valentina Salomoni, Carmelo Majorana and Alice Berardo
Biomedicines 2023, 11(7), 1942; https://doi.org/10.3390/biomedicines11071942
Available online: https://www.mdpi.com/2227-9059/11/7/1942
10. “MicroRNA Signatures in Cartilage Ageing and Osteoarthritis”
by Panagiotis Balaskas, Katarzyna Goljanek-Whysall, Peter D. Clegg, Yongxiang Fang, Andy Cremers, Aibek Smagul, Tim J. M. Welting and Mandy J. Peffers
Biomedicines 2023, 11(4), 1189; https://doi.org/10.3390/biomedicines11041189
Available online: https://www.mdpi.com/2227-9059/11/4/1189
We would like to take this opportunity to thank all the research groups that have submitted their papers to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:
Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.
Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.
Joining the Editorial Board:
If you are an active researcher in the fields of mineral processing and extractive metallurgy and are interested in joining the Editorial Board, please do not hesitate to get in touch (biomedicines@mdpi.com).
Biomedicines Editorial Office